Avatar Medical declared that their €5 million seed investment round has closed successfully. Leading the investment was GO Capital, with assistance from US-based Plug & Play, Acorn Pacific Ventures, Rives Croissance, and Cenitz. A total of fifteen radiologists and surgeons contributed to the financing round, demonstrating their strong support for this ground-breaking and inventive solution. With this funding, Avatar Medical will expedite the development of its AvatarCloud product and invest in commercialization across the US and Europe.

This investment represents a critical turning point for Avatar Medical. The company’s revolutionary technology immediately transforms medical photos into avatars tailored to each patient, with the aim of revolutionizing surgical consultations and improving the educational experience for medical students.

Surgeons may interact with patients in real time and in a straightforward, scalable manner by using Avatar Medical’s beautiful 3D and XR renderings in patient consultations. This transforms the way that surgeons and patients collaborate on decisions, improves surgical quality by streamlining digital planning, and gives hospitals a practical way to lower patient attrition and raise patient happiness. Using Avatar Medical also changes how anatomy, pathology, and radiology are taught to students.

“We are proud of all the achievements, from developing a unique solution to identifying the right go-to-market. This new milestone is very exciting as it gives us the means to launch the commercialization of our FDA-cleared solution in the US, while accelerating the sales to medical schools on both continents,” said Xavier Wartelle, CEO of Avatar Medical.

A group of businesspeople, physicists, engineers, and surgeons from France and the United States created Avatar Medical in 2020 as a spin-off of the Institut Pasteur and the Institut Curie. With its headquarters in both France and the US, it has received numerous honors, including distinction from Nvidia Inception, Laval Virtual, Medfit, and EIC Accelerator.

“From our very first meeting with Avatar Medical, we have been deeply impressed by the technology and its team. We are glad to back the company in its exciting journey,” added Frédéric Le Brun, partner at GO Capital.

Partner and analyst at Rives Croissance Benjamin Dejade said, “Avatar Medical offers a high-potential disruptive solution that Rives Croissance is proud to support.” Bruno Warnet also made this statement.